Testing effectiveness (Phase 2)Study completedNCT04698642
What this trial is testing
Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
Who this might be right for
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd. 43